Goldman Sachs’s Boston Scientific BSX Stock Holding History

Goldman Sachs’s Portfolio BSX Stock Details BSX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.5B	Buy	13,934,981 +5,149	+0%	+$553K	0.2%	64
2025 Q1	$1.41B	Buy	13,929,832 +1,044,524	+8%	+$105M	0.23%	53
2024 Q4	$1.15B	Sell	12,885,308 -357,229	-3%	-$31.9M	0.18%	69
2024 Q3	$1.11B	Sell	13,242,537 -186,272	-1%	-$15.6M	0.18%	77
2024 Q2	$1.03B	Sell	13,428,809 -1,237,659	-8%	-$95.3M	0.17%	84
2024 Q1	$1B	Sell	14,666,468 -1,360,025	-8%	-$93.1M	0.18%	83
2023 Q4	$926M	Sell	16,026,493 -591,845	-4%	-$34.2M	0.17%	82
2023 Q3	$877M	Sell	16,618,338 -2,152,877	-11%	-$114M	0.19%	78
2023 Q2	$1.02B	Buy	18,771,215 +897,259	+5%	+$48.5M	0.22%	58
2023 Q1	$894M	Sell	17,873,956 -86,573	-0.5%	-$4.33M	0.21%	68
2022 Q4	$831M	Sell	17,960,529 -1,504,520	-8%	-$69.6M	0.2%	71
2022 Q3	$754M	Buy	19,465,049 +5,062,939	+35%	+$196M	0.19%	76
2022 Q2	$537M	Sell	14,402,110 -3,443,340	-19%	-$128M	0.13%	103
2022 Q1	$790M	Sell	17,845,450 -1,110,661	-6%	-$49.2M	0.17%	82
2021 Q4	$805M	Buy	18,956,111 +2,669,063	+16%	+$113M	0.16%	84
2021 Q3	$707M	Buy	16,287,048 +885,503	+6%	+$38.4M	0.15%	103
2021 Q2	$659M	Sell	15,401,545 -1,188,807	-7%	-$50.8M	0.15%	101
2021 Q1	$641M	Buy	16,590,352 +1,950,892	+13%	+$75.4M	0.16%	88
2020 Q4	$526M	Buy	14,639,460 +1,619,967	+12%	+$58.2M	0.14%	103
2020 Q3	$497M	Sell	13,019,493 -1,138,244	-8%	-$43.5M	0.14%	103
2020 Q2	$497M	Buy	14,157,737 +182,943	+1%	+$6.42M	0.15%	107
2020 Q1	$456M	Sell	13,974,794 -690,962	-5%	-$22.5M	0.16%	95
2019 Q4	$663M	Buy	14,665,756 +1,325,017	+10%	+$59.9M	0.17%	97
2019 Q3	$543M	Buy	13,340,739 +567,189	+4%	+$23.1M	0.16%	99
2019 Q2	$549M	Buy	12,773,550 +441,275	+4%	+$19M	0.16%	99
2019 Q1	$473M	Sell	12,332,275 -1,545,680	-11%	-$59.3M	0.14%	104
2018 Q4	$490M	Sell	13,877,955 -1,854,595	-12%	-$65.5M	0.16%	89
2018 Q3	$606M	Sell	15,732,550 -4,828,750	-23%	-$186M	0.16%	93
2018 Q2	$672M	Buy	20,561,300 +1,751,488	+9%	+$57.3M	0.18%	80
2018 Q1	$514M	Buy	18,809,812 +6,146,291	+49%	+$168M	0.13%	143
2017 Q4	$314M	Buy	12,663,521 +4,219,434	+50%	+$105M	0.08%	243
2017 Q3	$246M	Buy	8,444,087 +1,106,056	+15%	+$32.3M	0.06%	289
2017 Q2	$203M	Buy	7,338,031 +1,752,426	+31%	+$48.6M	0.05%	339
2017 Q1	$139M	Buy	5,585,605 +276,013	+5%	+$6.86M	0.04%	469
2016 Q4	$115M	Sell	5,309,592 -300,290	-5%	-$6.5M	0.03%	558
2016 Q3	$134M	Sell	5,609,882 -977,484	-15%	-$23.3M	0.04%	469
2016 Q2	$154M	Buy	6,587,366 +2,960,198	+82%	+$69.2M	0.05%	374
2016 Q1	$68.2M	Sell	3,627,168 -1,225,878	-25%	-$23.1M	0.02%	728
2015 Q4	$89.5M	Buy	4,853,046 +2,868,278	+145%	+$52.9M	0.03%	590
2015 Q3	$32.6M	Sell	1,984,768 -2,938,044	-60%	-$48.2M	0.01%	1029
2015 Q2	$87.1M	Buy	4,922,812 +1,467,272	+42%	+$26M	0.03%	587
2015 Q1	$61.3M	Sell	3,455,540 -2,359,112	-41%	-$41.9M	0.02%	743
2014 Q4	$77M	Buy	5,814,652 +2,380,459	+69%	+$31.5M	0.02%	609
2014 Q3	$40.6M	Sell	3,434,193 -2,937,813	-46%	-$34.7M	0.01%	899
2014 Q2	$81.4M	Buy	6,372,006 +388,440	+6%	+$4.96M	0.03%	599
2014 Q1	$80.9M	Sell	5,983,566 -11,306,817	-65%	-$153M	0.03%	545
2013 Q4	$208M	Sell	17,290,383 -3,213,934	-16%	-$38.6M	0.07%	249
2013 Q3	$241M	Sell	20,504,317 -715,045	-3%	-$8.39M	0.09%	173
2013 Q2	$197M	Buy	+21,219,362	New	+$197M	0.08%	211